Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Buprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico.

Garcia CA, Correa GC, Viver AD, Kinlock TW, Gordon MS, Avila CA, Reyes IC, Schwartz RP.

J Addict Med. 2007 Sep;1(3):126-32. doi: 10.1097/ADM.0b013e31814b8880.

PMID:
21768947
2.

Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention.

Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, Wohl DA, Altice FL.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S78-83. doi: 10.1097/QAI.0b013e3181fbc94f.

PMID:
21406992
3.

Strategies to enhance linkages between care for HIV/AIDS in jail and community settings.

Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, Booker CA, Ferguson A, Figueroa H, Lincoln T, Ouellet LJ, Porterfield J, Spaulding AC, Tinsley MJ.

AIDS Care. 2011 Mar;23(3):366-77. doi: 10.1080/09540121.2010.507738.

PMID:
21347900
4.

Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users.

Copenhaver MM, Lee IC, Margolin A, Bruce RD, Altice FL.

Subst Abus. 2011 Jan;32(1):16-26. doi: 10.1080/08897077.2011.540466.

5.

Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research.

Bae JW, Guyer W, Grimm K, Altice FL.

AIDS. 2011 Jan 28;25(3):279-90. doi: 10.1097/QAD.0b013e328340feb0. Review.

PMID:
21239892
6.

HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.

Springer SA, Azar MM, Altice FL.

Am J Drug Alcohol Abuse. 2011 Jan;37(1):12-21. doi: 10.3109/00952990.2010.540280. Epub 2010 Dec 21. Review. Erratum in: Am J Drug Alcohol Abuse. 2011 May;37(3):203.

7.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.

8.

Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.

Wohl DA, Scheyett A, Golin CE, White B, Matuszewski J, Bowling M, Smith P, Duffin F, Rosen D, Kaplan A, Earp J.

AIDS Behav. 2011 Feb;15(2):356-64. doi: 10.1007/s10461-010-9843-4.

9.

Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Brust JC, Litwin AH, Berg KM, Li X, Heo M, Arnsten JH.

AIDS Res Hum Retroviruses. 2011 May;27(5):535-41. doi: 10.1089/aid.2010.0181. Epub 2010 Nov 23.

10.

Implementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence.

Leeman J, Chang YK, Lee EJ, Voils CI, Crandell J, Sandelowski M.

J Adv Nurs. 2010 Sep;66(9):1915-30. doi: 10.1111/j.1365-2648.2010.05360.x. Review.

11.

A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

Azar MM, Springer SA, Meyer JP, Altice FL.

Drug Alcohol Depend. 2010 Dec 1;112(3):178-93. doi: 10.1016/j.drugalcdep.2010.06.014. Epub 2010 Aug 11. Review.

12.

Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH.

Lancet. 2010 Jul 31;376(9738):367-87. doi: 10.1016/S0140-6736(10)60829-X. Review.

13.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

14.

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.

Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD.

Ann Intern Med. 2010 Jun 1;152(11):704-11. doi: 10.7326/0003-4819-152-11-201006010-00003.

15.

Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, Drobac PC, Shin SS.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):167-79. doi: 10.1097/QAI.0b013e3181d9a330. Review. Erratum in: J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):e37-8.

16.

Relationships over time between mental health symptoms and transmission risk among persons living with HIV.

Comulada WS, Rotheram-Borus MJ, Pequegnat W, Weiss RE, Desmond KA, Arnold EM, Remien RH, Morin SF, Weinhardt LS, Johnson MO, Chesney MA.

Psychol Addict Behav. 2010 Mar;24(1):109-118. doi: 10.1037/a0018190.

17.

Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Anand P, Springer SA, Copenhaver MM, Altice FL.

AIDS Behav. 2010 Dec;14(6):1213-26. doi: 10.1007/s10461-010-9684-1. Review.

18.

Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.

Springer SA, Chen S, Altice FL.

J Urban Health. 2010 Jul;87(4):592-602. doi: 10.1007/s11524-010-9438-4.

19.

Improving healthcare for incarcerated women.

Springer SA.

J Womens Health (Larchmt). 2010 Jan;19(1):13-5. doi: 10.1089/jwh.2009.1786. No abstract available.

20.

Supplemental Content

Support Center